When we compared the immune marker correlation for ESR1 and ESR2 specifically in breast cancer, it is striking that unlike ESR2, ESR1 in general exhibits a negative association with these antitumor immune markers (compare online supplemental figure S8D, E), supporting the notion that ERα and ERβ play opposite roles in tumor immune microenvironment. Here, ESR1 is linked to breast carcinoma.